Aflac, Inc.

  • Market Cap: Large Cap
  • Industry: Insurance
  • ISIN: US0010551028
USD
109.24
0.2 (0.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Aflac, Inc. stock-summary
stock-summary
Aflac, Inc.
Insurance
Aflac Incorporated is a business holding company. The Company is involved in supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). The Company's insurance business consists of two segments: Aflac Japan and Aflac U.S. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. The Company offers cancer plans, critical illness plans, and critical care and recovery plans. The Company designs the United States insurance products to provide supplemental coverage for people having medical or primary insurance coverage. Aflac U.S. offers accident coverage on both an individual and group basis. The Company offers cancer plans, critical illness plans, and critical care and recovery plans.
Company Coordinates stock-summary
Company Details
1932 WYNNTON RD , COLUMBUS GA : 31999
stock-summary
Tel: 1 706 3233431
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 147 Schemes (20.35%)

Foreign Institutions

Held by 360 Foreign Institutions (22.91%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Daniel Amos
Chairman of the Board, Chief Executive Officer
Mr. W. Paul Bowers
Lead Independent Director
Mr. Toshihiko Fukuzawa
Independent Director
Mr. Thomas Kenny
Independent Director
Ms. Georgette Kiser
Independent Director
Mrs. Karole Lloyd
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
599 Million
stock-summary
Industry

Insurance

stock-summary
Market cap

USD 130,221 Million (Large Cap)

stock-summary
P/E

36.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.02%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

8.96%

stock-summary
Price to Book

4.79